Cardiac Response and N-Terminal-Pro-Brain Natriuretic Peptide Kinetics During Exercise in Patients With COPD

References

1. 1.↵
   1. Celli B,
   2. MacNee W

   ; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932–946. Erratum in: Eur Respir J 2006;27(1):242.

   OpenUrlFREE Full Text
2. 2.↵
   1. Mannino DM,
   2. Watt G,
   3. Hole D,
   4. Gillis C,
   5. Hart C,
   6. McConnachie A,
   7. et al

   . The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006;27(3):627–643.

   OpenUrlFREE Full Text
3. 3.
   1. Wang HY,
   2. Xu QF,
   3. He X,
   4. Nie S

   . Survey of comorbid diseases in patients with COPD in Beijing (abstract). Am J Respir Crit Care Med 2010;181(Suppl):5936.

   OpenUrl
4. 4.↵
   1. Mannino DM,
   2. Thorn D,
   3. Swensen A,
   4. Holguin F

   . Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32(4):962–969.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Gardner RS,
   2. Ozalp F,
   3. Murday AJ,
   4. Robb SD,
   5. McDonagh TA

   . N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24(19):1735–1743.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Wu AH,
   2. Smith A,
   3. Wieczorek S,
   4. Mather JF,
   5. Duncan B,
   6. White CM,
   7. et al

   . Biological variation for N-terminal pro and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003;92(5):628–631.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Thaman R,
   2. Esteban MT,
   3. Barnes S,
   4. Gimeno JR,
   5. Mist B,
   6. Murphy R,
   7. et al

   . Usefulness of N-Terminal Pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy. Am J Cardiol 2006;98(4):515–519.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Lainchbury JG,
   2. Campbell E,
   3. Frampton CM,
   4. Yandle TG,
   5. Nicholls MG,
   6. Richards AM,
   7. et al

   . Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42(4):728–735.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Plankeel J,
   2. McMullen B,
   3. Macintyre NR

   . Exercise outcomes after pulmonary rehabilitation depend on the initial mechanism of exercise limitation among non-oxygen-dependent COPD patients. Chest 2005;127(1):110–116.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1994;152(3):1107–1136.

    OpenUrlWeb of Science
11. 11.↵
    American Thoracic Society; American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167(2):211–277.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. O'Donnell DE,
    2. Revill SM,
    3. Webb KA

    . Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(5):770–777.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.
    1. Saey D,
    2. Michaud A,
    3. Couillard A,
    4. Côté CH,
    5. Mador MJ,
    6. LeBlanc P,
    7. et al

    . Contractile fatigue, muscle morphometry and blood lactate in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171(10):1109–1115.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Funk GC,
    2. Lang I,
    3. Schenk P,
    4. Valipour A,
    5. Hartl S,
    6. Burghuber OC

    . Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure. Chest 2008;133(6):1354–1359.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Oga T,
    2. Nishimura K,
    3. Tsukino M,
    4. Sato S,
    5. Hajiro T,
    6. Mishima M

    . Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest 2005;128(1):62–69.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Passino C,
    2. Poletti R,
    3. Bramanti F,
    4. Prontera C,
    5. Clerico A,
    6. Emdin M

    . Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. Eur J Heart Fail 2006;8(1):46–53.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Blyth KG,
    2. Groenning BA,
    3. Mark PB,
    4. Martin TN,
    5. Foster JE,
    6. Steedman T,
    7. et al

    . NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J 2007;29(4):737–744.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Stewart RI,
    2. Lewis CM

    . Cardiac output during exercise in patients with COPD. Chest 1986;89(2):199–205.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Krüger S,
    2. Graf J,
    3. Merx MW,
    4. Stickel T,
    5. Kunz D,
    6. Hanrath P,
    7. et al

    . Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure. Int J Cardiol 2004;95(1):49–54.

    OpenUrlCrossRefPubMedWeb of Science